Long COVID Patterns in the RECOVER-Adult Study
November 21, 2025
Brand Name :
Symbyax
Synonyms :
olanzapine/fluoxetine
Class :
Psychotherapeutic combinations
Dosage Forms & StrengthsÂ
CapsuleÂ
3mg/25mg (olanzapine/fluoxetine)Â
6mg/25mg (olanzapine/fluoxetine)Â
6mg/50mg (olanzapine/fluoxetine)Â
12mg/25mg (olanzapine/fluoxetine)Â
12mg/50mg (olanzapine/fluoxetine)Â
Take an initial dose of 6 mg/25 mg orally every day in the evening
If required, it may titrate with 6 to 12 mg olanzapine/25 to 50 mg fluoxetine drug
Daily dose should not be more than 18 mg/75 mg
Treatment of Resistant Depression
Take initial dose of 6 mg/25 mg orally daily in evening
Dosage Modifications
Hypotensive diathesis and hepatic impairment: start with dose of 3 mg/25 mg to 6 mg/25 mg orally daily
In females, elderly peoples and nonsmokers the slow metabolism is observed
Don’t initiate the drug (fluoxetine/olanzapine) in patients treated with linezolid
Dosing Considerations
Allow minimum two weeks to elapse before starting fluoxetine/olanzapine drug after discontinuation of a monoamine oxidase inhibitor used in the treatment of psychiatric disorders
Similarly, allow minimum 5 weeks after stopping fluoxetine/olanzapine drug before starting a monoamine oxidase inhibitor used in the treatment of psychiatric disorders
Dosage Forms & StrengthsÂ
CapsuleÂ
3mg/25mg (olanzapine/fluoxetine)Â
6mg/25mg (olanzapine/fluoxetine)Â
6mg/50mg (olanzapine/fluoxetine)Â
12mg/25mg (olanzapine/fluoxetine)Â
12mg/50mg (olanzapine/fluoxetine)Â
for <10 years old: Safety and efficacy not determined
for 10 to 17 years old:
Take an initial dose of 3 mg/25 mg orally every day in the evening
If required, it may titrate with 6 to 12 mg olanzapine/25 to 50 mg fluoxetine drug
Daily dose should not be more than 12 mg/50 mg
Refer to adult dosingÂ
Actions and SpectrumÂ
olanzapine is an antipsychotic drug. It works by antagonizing certain receptors in the brain, specifically serotonin (5-HT2A/2C), dopamine (D1-4), histamine (H1), and alpha-adrenergic receptors.Â
fluoxetine is a selective serotonin reuptake inhibitor (SSRI). It works by inhibiting the reuptake of serotonin in the brain, leading to increased levels of serotonin in the synapses.
Frequency not defined Â
For fluoxetineÂ
Erythema multiformeÂ
Cataract, cerebrovascular accidentÂ
Pulmonary hypertensionÂ
Stevens-Johnson syndromeÂ
Aplastic anemiaÂ
Cholestatic jaundiceÂ
Eosinophilic pneumoniaÂ
Violent behavior, atrial fibrillationÂ
Epidermal necrolysisÂ
HypoglycemiaÂ
Kidney failure Â
Memory impairment, optic neuritisÂ
Erythema nodosum  Â
Heart arrest Â
For olanzapineÂ
Stuttering Â
Diabetic ketoacidosisÂ
Drug reaction with eosinophilia and systemic symptoms Â
Salivary hypersecretionÂ
Diabetic comaÂ
JaundiceÂ
Allergic reaction Â
Black Box WarningÂ
Patients should be continuously watched for behavioural changes, clinical deterioration, and suicidal ideation. Short-term controlled trials have indicated that patients with dementia-related psychosis who are treated with antipsychotic medications have an increased risk of death. This combination drug is not approved for the treatment of patients with dementia-related psychosisÂ
Contraindication/Caution:Â
Contraindication:Â
Caution:Â
Pregnancy consideration:Â
Pregnancy category: N/AÂ
Lactation: both drugs are excreted into human breast milk Â
Pregnancy Categories:        Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.Â
<b>Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.Â
Category N: There is no data available for the drug under this category.Â
Pharmacology Â
olanzapine blocks these serotonin (5-HT2A/2C), dopamine (D1-4), histamine (H1) receptors and exerts its therapeutic effects by modulating the levels of various neurotransmitters, particularly serotonin and dopamine. Â
fluoxetine works by selectively inhibiting the reuptake of serotonin in the brain. The enhancement of serotonin neurotransmission helps to regulate mood, emotions, and anxiety by influencing various serotonin pathways in the brain.Â
PharmacodynamicsÂ
olanzapine helps to alleviate positive and negative symptoms of psychosis, such as hallucinations and delusions, while also stabilizing mood and reducing agitation.Â
By targeting serotonin pathways, fluoxetine alleviates symptoms of depression and certain anxiety disorders. Â
PharmacokineticsÂ
Absorption  Â
olanzapine is well-absorbed and reaches peak plasma concentrations within 5 to 8 hours after taking orally.Â
while fluoxetine is also well-absorbed after oral administration and has a long half-life. Â
DistributionÂ
olanzapine/fluoxetine both are extensively distributed throughout the body’s tissues.Â
MetabolismÂ
olanzapine undergoes extensive hepatic metabolism, primarily via the cytochrome P450 enzyme CYP1A2. Â
fluoxetine is also extensively metabolized in the liver by CYP2D6 and CYP2C19 enzymes. Â
Elimination and excretionÂ
olanzapine/ fluoxetine both eliminated through the feces and urine.
AdministrationÂ
olanzapine/fluoxetine drug mainly available in capsules for oral administration.
Patient information leafletÂ
Generic Name: olanzapine/fluoxetineÂ
Why do we use olanzapine/fluoxetine?Â
olanzapine/fluoxetine is a combination drug which used in treatment for certain types of depression, particularly bipolar depression, which involves episodes of both depression and mania or hypomania. Â
olanzapine is used to treat conditions such as schizophrenia, bipolar disorder including both manic and mixed episode. fluoxetine is mainly used to treat major depressive disorder, obsessive-compulsive disorder (OCD), bulimia nervosa, and panic disorder.Â